Company / Depreciation & Amortization
Wave Life Sciences Ltd. Depreciation & Amortization History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$7.5M
FY2022
5-year range
$7.5M / $8.1M
FY2018-FY2022
Trend
-7.8%
vs FY2021
Sector context
#73 of 168
Health Care
What the data says
At $7M, Wave Life Sciences Ltd.'s depreciation & amortization ranks #96 of 168 in the Health Care sector.
Based on SEC 10-K filings.
$7M in FY2022 with a 5-year CAGR of +28.3%.
Remained stable around $7M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +51.4%
- 5-Year CAGR
- +28.3%
- 10-Year CAGR
- -
Sector benchmark
#96 of 168 in Health CareTop 57% of 168This company $7.5M Sector average $212.9M
▼
-96.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +28.3%, indicating consistent growth.
- In FY2022, depreciation & amortization decreased 7.8% year-over-year.
- Ranks #73 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $7.5M | -7.8% |
| FY2021 | $8.1M | +6.9% |
| FY2020 | $7.6M | +252.1% |
| FY2019 | $2.2M | - |
| FY2018 | - | - |
| FY2017 | $2.2M | +174.9% |
| FY2016 | $784.0K | +184.1% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026